DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $332,883 | -7.6% | 1,321 | -2.7% | 0.02% | -11.5% |
Q4 2022 | $360,361 | -4.9% | 1,358 | -7.6% | 0.03% | -10.3% |
Q3 2022 | $379,000 | +2.4% | 1,469 | +0.7% | 0.03% | +7.4% |
Q2 2022 | $370,000 | -11.7% | 1,459 | +2.2% | 0.03% | -3.6% |
Q1 2022 | $419,000 | +6.3% | 1,427 | +19.3% | 0.03% | +12.0% |
Q4 2021 | $394,000 | -10.5% | 1,196 | -17.2% | 0.02% | -19.4% |
Q3 2021 | $440,000 | +0.5% | 1,445 | -11.6% | 0.03% | +6.9% |
Q2 2021 | $438,000 | +37.3% | 1,635 | +15.2% | 0.03% | +26.1% |
Q1 2021 | $319,000 | +1.9% | 1,419 | +0.7% | 0.02% | -4.2% |
Q4 2020 | $313,000 | +52.7% | 1,409 | +48.3% | 0.02% | +20.0% |
Q3 2020 | $205,000 | -6.4% | 950 | -62.8% | 0.02% | -62.3% |
Q2 2015 | $219,000 | -1.8% | 2,556 | -2.7% | 0.05% | -26.4% |
Q1 2015 | $223,000 | -35.7% | 2,626 | -40.5% | 0.07% | -31.4% |
Q2 2014 | $347,000 | +3.6% | 4,411 | -1.2% | 0.10% | +1.9% |
Q1 2014 | $335,000 | -8.0% | 4,465 | -5.3% | 0.10% | -8.0% |
Q4 2013 | $364,000 | -5.0% | 4,717 | -14.5% | 0.11% | -11.8% |
Q3 2013 | $383,000 | -0.5% | 5,519 | -9.2% | 0.13% | -9.9% |
Q2 2013 | $385,000 | – | 6,077 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CORTLAND ASSOCIATES INC/MO | 752,930 | $52,193,000 | 11.19% |
RobecoSam USA, Inc. | 119,035 | $8,252,000 | 10.58% |
Consulta Ltd | 689,081 | $47,767,000 | 7.32% |
Robeco Schweiz AG | 978,700 | $68,382,000 | 5.73% |
Five Oceans Asset Management LTD | 255,259 | $17,695,000 | 5.22% |
GENERATION INVESTMENT MANAGEMENT LLP | 3,825,008 | $265,150,000 | 5.04% |
ASHMORE WEALTH MANAGEMENT LLC | 3,300,000 | $228,756,000 | 4.98% |
DAVIS-REA LTD. | 89,193 | $6,183,000 | 4.79% |
CADINHA & CO LLC | 332,935 | $23,079,000 | 4.63% |
VIKING GLOBAL INVESTORS LP | 11,436,737 | $792,794,000 | 4.38% |